Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Alpha Cognition Inc C.ACOG

Alternate Symbol(s):  ACOGD

Alpha Cognition Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is engaged in developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company’s pipeline includes ALPHA-1062, ALPHA-0602, and ALPHA-0702 and ALPHA-0802 (GEMs). The Company’s ALPHA-1062 is a patented new chemical entity being developed as a new generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease, with expected minimal gastrointestinal side effects. ALPHA-1062 is also being developed in combination with memantine to treat moderate to severe Alzheimer’s dementia, and as an intranasal formulation for Cognitive Impairment with mTBI. ALPHA-0602 is a gene therapy program delivering progranulin, a neurotrophic protein. It is in preclinical development for the treatment of ALS.


CSE:ACOG - Post by User

Post by partystockeron Oct 01, 2021 11:29am
140 Views
Post# 33952328

Big day for $ACOG, my current top pick!!

Big day for $ACOG, my current top pick!!

They just announced they closed their public offering and raised $14.4M! $ACOG.V issued 9.6M units at $1.50 per unit. 


Warrants are gonna start trading on the TSXV under ticker $ACOG.WT next week!


$ACOG is gonna be using the $$ made from the offering for development and marketing of ALPHA-1062, the company’s lead developmental treatment candidate atm. 


PLUS they just formed a Scientific Advisory Board that's packed with pros from the neurology and psychiatry industry. The board is gonna be working to bring $ACOG closer to commercialization. 


they will also have a huge focus on developing products that can treat neurological diseases with unmet needs, like dementia and Alzheimer's, and furthering developing ALPHA-1062.


I have no doubt the new SAB will speed up the process of the company becoming the creator of the world’s first Alzheimer’s treatment. I just am so stoked to see all this progress happening for the company!! 


Td, $ACOG is up at $1.37, MC $71.03M.

 
<< Previous
Bullboard Posts
Next >>